In recent years, lung cancer rates have been rising in nonsmokers, a troubling trend for the world's #1 deadliest cancer. Sybil is a deep learning model built by MIT Jameel Clinic and Mass General Brigham researchers that accurately predicts lung cancer risk up to 6 years in advance by analyzing a patient's LDCT scan.
How exactly does this state-of-the-art model work and what was the key insight that brought it to life? Watch this 7-minute video featuring the researchers behind the model to learn more about how Sybil is transforming the future of lung cancer screening. Learn more
Artificial intelligence often gets criticized because it makes up information that appears to be factual, known as hallucinations. The plausible fakes have roiled not only chatbot sessions but lawsuits and medical records. For a time last year, a patently false claim from a new Google chatbot helped drive down the company’s market value by an estimated $100 billion.
In the universe of science, however, innovators are finding that A.I. hallucinations can be remarkably useful. The smart machines, it turns out, are dreaming up riots of unrealities that help scientists track cancer, design drugs, invent medical devices, uncover weather phenomena and even win the Nobel Prize. Learn more
MIT scientists have released a powerful, open-source AI model, called Boltz-1, that could significantly accelerate biomedical research and drug development.
Developed by a team of researchers in the MIT Jameel Clinic for Machine Learning in Health, Boltz-1 is the first fully open-source model that achieves state-of-the-art performance at the level of AlphaFold3, the model from Google DeepMind that predicts the 3D structures of proteins and other biological molecules.
MIT graduate students Jeremy Wohlwend and Gabriele Corso were the lead developers of Boltz-1, along with MIT Jameel Clinic Research Affiliate Saro Passaro and MIT professors of electrical engineering and computer science Regina Barzilay and Tommi Jaakkola. Wohlwend and Corso presented the model at a Dec. 5 event at MIT’s Stata Center, where they said their ultimate goal is to foster global collaboration, accelerate discoveries, and provide a robust platform for advancing biomolecular modeling. Learn more
Biocon Founder, Chairman and Managing Director and Advisory Board member of MIT Jameel Clinic Kiran Mazumdar-Shaw was recognized in Forbes' 2024 list of the World's Most Powerful Women. The list recognizes 100 exceptional women in fields such as finance, technology, media and beyond, who have significant visibility and economic impact, influencing over 1 billion people around the world. Learn more